Age, Ki-67, Nodal PCR and overall survival following Neoadjuvant Chemotherapy for Node Positive ER+/HER2- Breast Cancer
Dan Moldoveanu, M.D., M.Ch.

Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer - Results from MACOSOG Z11102 (Alliance)
Judy C. Boughey, M.D.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Describe the relationship between age, Ki67 expression and nodal pathological complete response hormone receptor positive Her2 negative node positive breast cancer patients
• Describe the relationship between nodal pathological complete response and overall survival in hormone receptor positive Her2 negative node positive breast cancer patients
• Discuss the potential role of nodal pathological complete response as a surrogate marker for neoadjuvant chemotherapy response
• Describe the local recurrence rate after breast conserving therapy for patients with multiple ipsilateral breast cancer

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenters:
Dan Moldoveanu, M.D., M.Ch.
Judy C. Boughey, M.D.

Support location:
Minnesota